Study examines increased physical activity may lower the risk for several cancers and may be beneficial for improving quality of life.
ICU and hospital mortality were lower for patients with cancer vs those without cancer.
Standardized definition and guidance on estimation may facilitate understanding of cancer overdiagnosis.
Post-traumatic stress symptoms were also linked to lower risk of readmission in hospitalized patients with cancer.
Awake video-assisted thoracoscopic surgery was safe and feasible in some patients with poor lung function and lung cancer.
A history of chronic inflammatory lung disease appears to increase the risk of developing non-small cell lung cancer.
Targeted sequencing, whole-genome sequencing, and whole-genome bisulfite sequencing showed potential for detecting lung cancer.
Pembrolizumab improved overall survival vs chemotherapy regardless of the programmed death ligand 1 tumor proportion score.
A total of 8 quantitative radiologic features were used to characterize indeterminate screen-detected lung nodules.
Merck initially gained accelerated approval for Keytruda with Alimta and carboplatin in May 2017.
Researchers created a web-based decision tool to facilitate personalized discussions regarding lung cancer screening.
Researchers examined nationwide population-based incidence of lung cancer according to sex, race or ethnic group, age group, birth year, and calendar period of diagnosis.
Bioengineered tracheal and bronchial reconstruction was conducted using stented aortic matrices.
The most eligible smokers were populated in South, which had most screening sites but the low screening rates
Four models were well-calibrated and had higher areas under the curve than 5 models that overestimated lung cancer risk.
Serum CKAP4 levels of lung cancer patients were significantly higher than those of healthy controls.
Prostate and lung cancer expected to emerge as the most common types by 2030.
For clinical stage 1 non-small-cell lung cancer, 21.7% of patients upstaged after 1 week and 31.5% after 8 weeks.
More cancer survivors prescribed 5 or more unique medications, including medications with abuse potential.
Researchers developed an algorithmic approach to diagnosing lung cavitary diseases.
Nivolumab plus ipilimumab linked to better survival in NSCLC with high tumor mutational burden.